Henry Schein appoints Frederick M. Lowery as CEO

MELVILLE, N.Y., US: Henry Schein has introduced the appointment of Frederick M. Lowery as CEO, efficient from 2 March. Lowery can even sign up for the corporate’s board of administrators at the moment. He succeeds Stanley M. Bergman, who will step down after 35 years within the position and proceed to function chairman of the board to toughen a clean management transition.

The appointment follows Henry Schein’s announcement in July 2025 that Bergman would retire as CEO on the finish of the yr. Bergman joined the corporate in 1980 as its first leader monetary officer and assumed management in 1989 after the demise of then CEO Jay Schein. Below his tenure, Henry Schein reworked from a US-based dental mail order trade into an international supplier of dental and clinical merchandise and answers.

Lowery brings greater than twenty years of revel in in healthcare management to Henry Schein. Maximum not too long ago, he served as govt vice-president and president of laboratory merchandise and bio-production at Thermo Fisher Medical, the place he led the corporate’s international distribution operations to above-market efficiency. His background spans distribution, production, analysis and construction, advertising and marketing and gross sales, aligning carefully with Henry Schein’s trade style and its 2025–2027 BOLD+1 strategic plan, which emphasises higher-margin distinctiveness, generation and value-added expansion along international distribution.

“I’m honoured to sign up for Henry Schein at this sort of pivotal second. That is an organisation with immense attainable to affect clinicians and sufferers, given its outstanding recognition for innovation, customer support and partnership,” Lowery mentioned in a press liberate. “I sit up for operating with Crew Schein to construct at the sturdy basis established by means of Stan whilst accelerating cost introduction.”

“I’m more than happy to welcome Fred to Henry Schein,” mentioned Bergman. “Past his in depth operational revel in, he brings a management philosophy that displays the values that experience lengthy outlined our corporate. Fred understands the essential position we play in supporting dental and clinical practitioners, and he’s exceptionally smartly supplied to steer Henry Schein into its subsequent segment of expansion.”

The CEO succession procedure used to be overseen by means of the nominating and governance committee. Committee Chair Philip A. Laskawy, additionally lead director of Henry Schein, mentioned: “After a complete seek procedure, we’re assured that Fred is the proper successor to honour Henry Schein’s proud heritage and boost up expansion and cost introduction.”

The appointment comes in opposition to the backdrop of Henry Schein’s strategic partnership with funding company KKR, which bought a vital minority stake within the corporate in 2025 and appointed representatives to the board. Max Lin, vice-chair of the nominating and governance committee and a spouse at KKR, added: “We consider Fred brings a novel aggregate of healthcare distribution revel in, operational easiest practices and responsible management that may boost up our strategic tasks and extra differentiate Henry Schein as a world-class trade.”

Previous to becoming a member of Thermo Fisher, Lowery held management roles on the Maytag Corp. and Basic Motors. He holds a grasp’s stage in production control from Kettering College (then the GMI Engineering and Control Institute) in Flint in Michigan and a bachelor’s stage in mechanical engineering from Tennessee Technological College in Cookeville, each in the USA.